Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Thromboembolic Events in Patients Undergoing Gastrointestinal Cancer Surgery and Thromboprophylactic Treatment With Two Enoxaparin Formulations (ENOXA® vs Lovenox®)

NCT02444572 is registered in ClinicalTrials.gov with Les Laboratoires des Médicaments Stériles as lead sponsor.

NCT NCT02444572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02444572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Thromboembolic Events in Patients Undergoing Gastrointestinal Cancer Surgery and Thromboprophylactic Treatment With Two Enoxaparin Formulations (ENOXA® vs Lovenox®)
Lead sponsor
Les Laboratoires des Médicaments Stériles
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2015
Completion date
July 10, 2020
Enrollment
168 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal neoplasms, thromboembolic event